Multiple endogenous receptors and matrix components

Multiple endogenous receptors and matrix components is a descriptive term used in pharmacological databases to categorize the non-specific sites of action for diagnostic agents, primarily gadolinium-based contrast agents (GBCAs) [DrugBank DB09132]. These agents do not bind to a single, specific molecular target; instead, they distribute throughout the extracellular fluid and interact with a variety of cell surface receptors and structural elements of the extracellular matrix [PubChem CID 119541]. This broad interaction allows the agents to modify the magnetic properties of the surrounding environment, which is essential for enhancing contrast in Magnetic Resonance Imaging (MRI) [StatPearls: Gadolinium Contrast Media]. While these components are critical for maintaining tissue architecture and physiological signaling, their role as a target is largely passive, facilitating the visualization of tissue vascularity and pathology. Clinical management of drugs interacting with these components focuses on renal function, as impaired clearance can lead to serious complications like Nephrogenic Systemic Fibrosis (NSF) [FDA Drug Safety Communication, 2010]. Consequently, this target represents a functional grouping for pharmacokinetic and diagnostic purposes rather than a specific therapeutic site. The interaction with the matrix is also a factor in the long-term retention of certain agents in bone and brain tissue, which remains a subject of ongoing safety monitoring [EMA, 2017].

Other names

Extracellular matrix componentsNon-specific tissue targetsEndogenous receptors (multiple)

These agents distribute into the extracellular space and interact non-specifically with various endogenous receptors and matrix components to alter the relaxation times of nearby water protons, thereby enhancing image contrast in magnetic resonance imaging (MRI) [DrugBank, StatPearls].